Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 119
Filter
1.
Hipertens. riesgo vasc ; 41(1): 5-16, Ene-Mar, 2024. tab, graf
Article in English | IBECS | ID: ibc-231662

ABSTRACT

Background: Cardiovascular disease (CVD) is one of the principal causes of death in antineutrophil cytoplasmic antibody-(ANCA)-associated vasculitis (AAV). Objectives: To evaluate the mortality and it's causes and CVD and its vascular risk factors (VRFs) in AAV patients in Andalusia. Methods: A multicenter cohort of 220 AAV patients followed-up from 1979 until June 2020 was studied in Andalussia, south of Spain. The information, including socio-demographic and clinical data was recorded retrospectively through chart review. Data was analysed using Chi2, ANOVA and Cox proportional hazards regresion as uni and multivariate test with a 95% confidence interval (CI). Results: During a mean ± standard deviation follow-up of 96.79 ± 75.83 months, 51 patients died and 30 presented at least one CVE. Independent prognostic factors of mortality were age (HR 1.083, p=0.001) and baseline creatinine (HR 4.41, p=0.01). Independent prognostic factors of CVE were age [hazard ratio (HR) 1.042, p=0.005] and the presence of hypertension (HTN) six months after diagnosis (HR 4.641, p=0.01). HTN, diabetes and renal failure, all of these important VRFs, are more prevalent in AAV patients than it is described in matched general population. Conclusions: Age and baseline renal function, but not CVEs, are predictors of mortality and age and early HTN are independent predictors for having a CVE. CVD screening in AAV patients is demanded.(AU)


Introducción: La enfermedad cardiovascular (ECV) es una de las principales causas de muerte en las vasculitis asociadas a anticuerpos anticitoplasma de neutrófilos (ANCA) (VAA). Objetivos: Evaluar la mortalidad y sus causas, entre ellas la ECV y sus factores de riesgo vascular (FRV) en pacientes con VAA en Andalucía. Métodos: Se estudió una cohorte multicéntrica de 220 pacientes con VAA seguidos desde 1979 hasta junio de 2020 en Andalucía. La información, incluidos los datos sociodemográficos y clínicos, se registró retrospectivamente a través de la revisión de historias clínicas. Los datos se analizaron mediante Chi2, ANOVA y regresión de riesgos proporcionales de Cox de forma uni y multivariante con un intervalo de confianza (IC) del 95%. Resultados: Durante un seguimiento medio y desviación estándar de 96,79 ± 75,83 meses, 51 pacientes fallecieron y 30 presentaron al menos un ECV. Los factores pronósticos independientes de mortalidad fueron la edad (HR 1,083, p=0,001) y la creatinina basal (HR 4,41, p=0,01). Los factores pronósticos independientes de ECV fueron la edad [hazard ratio (HR) 1,042, p=0,005] y la presencia de hipertensión arterial (HTA) seis meses después del diagnóstico (HR 4,641, p=0,01). La prevalencia de HTA, diabetes e insuficiencia renal fue elevada o muy elevada en comparación con la población general emparentada, todos FRCV determinantes para el pronóstico de estos pacientes. Conclusiones: La edad y la función renal basal son predictores de mortalidad y la edad y la HTA de aparición precoz son predictores independientes de tener ECV. Se recomienda el cribado de FRCV en pacientes con vasculitis ANCA.(AU)


Subject(s)
Humans , Male , Female , Cardiovascular Diseases/mortality , Hypertension , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , Spain , Cohort Studies , Risk Factors
2.
Hipertens Riesgo Vasc ; 41(1): 5-16, 2024.
Article in English | MEDLINE | ID: mdl-37517951

ABSTRACT

BACKGROUND: Cardiovascular disease (CVD) is one of the principal causes of death in antineutrophil cytoplasmic antibody-(ANCA)-associated vasculitis (AAV). OBJECTIVES: To evaluate the mortality and it's causes and CVD and its vascular risk factors (VRFs) in AAV patients in Andalusia. METHODS: A multicenter cohort of 220 AAV patients followed-up from 1979 until June 2020 was studied in Andalussia, south of Spain. The information, including socio-demographic and clinical data was recorded retrospectively through chart review. Data was analysed using Chi2, ANOVA and Cox proportional hazards regresion as uni and multivariate test with a 95% confidence interval (CI). RESULTS: During a mean ± standard deviation follow-up of 96.79 ± 75.83 months, 51 patients died and 30 presented at least one CVE. Independent prognostic factors of mortality were age (HR 1.083, p=0.001) and baseline creatinine (HR 4.41, p=0.01). Independent prognostic factors of CVE were age [hazard ratio (HR) 1.042, p=0.005] and the presence of hypertension (HTN) six months after diagnosis (HR 4.641, p=0.01). HTN, diabetes and renal failure, all of these important VRFs, are more prevalent in AAV patients than it is described in matched general population. CONCLUSIONS: Age and baseline renal function, but not CVEs, are predictors of mortality and age and early HTN are independent predictors for having a CVE. CVD screening in AAV patients is demanded.


Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , Cardiovascular Diseases , Hypertension , Humans , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/epidemiology , Antibodies, Antineutrophil Cytoplasmic , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Heart Disease Risk Factors , Hypertension/complications , Hypertension/epidemiology , Kidney , Retrospective Studies , Risk Factors , Spain/epidemiology
3.
Arch. prev. riesgos labor. (Ed. impr.) ; 25(3): 285-299, jul. 15 2022. tab
Article in Spanish | IBECS | ID: ibc-209113

ABSTRACT

Objetivo: Analizar las propiedades psicométricas de las escalas de demandas de la batería UNIPSICO del contexto de trabajo en valenciano/catalán.Método: La muestra la constituyen 2114 trabajadores de centros públicos de la Generalitat Valenciana, de la provincia de Valencia. La recogida de datos se realizó mediante las esca-las de la batería UNIPSICO que evalúan factores psicosociales de demandas en el trabajo (33 ítems), que se agrupan en 6 escalas: Conflicto de rol (5 ítems), ambigüedad de rol (5 ítems), carga de trabajo (6 ítems), conflictos interpersonales (6 ítems), inequidad en los intercambios sociales (5 ítems), y conflicto trabajo-familia/familia-trabajo (6 ítems). Se rea-lizó un análisis factorial confirmatorio (AFC) y se calcularon los valores alfa de Cronbach y omega de McDonald para las escalas.Resultados: Todos los ítems presentaron valores estadísticos y psicométricos adecuados. El modelo de seis factores que reproduce la estructura original del cuestionario presentó un ajuste adecuado a los datos, con invarianza de sexo. El valor del alfa de Cronbach y omega de McDonald resultó aceptable para las seis escalas del instrumento.Conclusiones: Estos resultados contribuyen a la validación psicométrica del cuestionario, permitiendo concluir que las escalas de demandas de la batería UNIPSICO, en valenciano/catalán resulta un instrumento fiable y con consistencia interna para evaluar los riesgos psicosociales en personal que trabaja en la administración (AU)


Aim: To analyse the psychometric properties of the demand scales of the UNIPSICO ques-tionnaire in in Valencian / Catalan language.Method: The sample consisted of 2114 participants from public administration centres of Generalitat Valenciana in Valencia. Data were collected using the UNIPSICO questionnaire, which is grouped into six scales that measure psychosocial risk factors related to job de-mands (33 items): role conflict (5 items), role ambiguity (5 items), workload (6 items), in-terpersonal conflicts (6 items), inequity in social exchanges (5 items), and work-family and family-work conflict (6 items). We performed confirmatory factor analysis (CFA) and mea-sured Cronbach alpha and McDonald omega coefficients for the scales.Results: All items had adequate statistical and psychometric values. The six-factor model that reproduces the original structure of the questionnaire presented an adequate fit to the data, and gender invariance. The Cronbach alpha and McDonald omega coefficients were acceptable for the six scales of the instrument.Conclusions: These results contribute to the psychometric validation of the questionnaire and allow us to conclude that the demand scales of the UNIPSICO questionnaire translated to Valencian / Catalan language are reliable and possess construct validity for the assess-ment of psychosocial risk factors in government employees (AU)


Subject(s)
Humans , Male , Female , Young Adult , Adult , Middle Aged , Aged , Surveys and Questionnaires , Occupational Health , Psychosocial Impact , Psychometrics , Factor Analysis, Statistical
4.
Rev. clín. esp. (Ed. impr.) ; 221(10): 592-595, dic. 2021. tab
Article in Spanish | IBECS | ID: ibc-227039

ABSTRACT

Introducción El efecto de la dexametasona en la fase inicial de la infección por SARS-CoV-2 y su influencia sobre la COVID-19 no está bien definido. Describimos las características clínico-radiológicas, los parámetros de tormenta de citoquinas y la evolución clínica de una serie de pacientes tratados con dexametasona en la fase inicial de la enfermedad. Método Estudio de 8 pacientes que recibieron dexametasona previo al desarrollo de la COVID-19. Evaluamos variables clínicas, pruebas de imagen, parámetros de liberación de citoquinas, tratamiento empleado y su evolución. Resultados Todos los pacientes recibieron una dosis de 6mg/día con una duración media de 4,5 días previos al ingreso. La mayoría de los pacientes presentaron una extensión grave en la tomografía computarizada de alta resolución (TCAR) y una elevación leve de los parámetros de liberación de citoquinas; 3 pacientes requirieron oxigenoterpia nasal de alto flujo (ONAF) por insuficiencia respiratoria, y ningún paciente requirió intubación orotraqueal ni falleció. Conclusión La dexametasona en las fases iniciales de la infección por SARS-CoV-2 parece asociarse con una COVID-19 grave (AU)


Introduction The effect of dexamethasone in the initial phase of infection by SARS-CoV-2 and its influence on COVID-19 is not well defined. We describe clinical-radiological characteristics, the cytokine storm parameters, and the clinical evolution of a series of patients treated with dexamethasone in the disease's initial phase. Method A study of 8 patients who received dexamethasone before the development of COVID-19. We evaluate clinical variables, imaging tests, cytokine release parameters, treatment used and patient evolution. Results All patients received a 6mg/day dose with a mean duration of 4.5 days before admission. High resolution computed tomography (HRCT) revealed that most of them presented a severe extension; most patients had a slightly elevated level of cytokine release parameters. Three patients required high-flow oxygen therapy due to respiratory failure; none required orotracheal intubation or died. Conclusion Dexamethasone in the early stages of SARS-CoV-2 infection appears to be associated with severe COVID-19 (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Dexamethasone/administration & dosage , Anti-Inflammatory Agents/administration & dosage , /drug therapy , Severity of Illness Index , Retrospective Studies
5.
Rev Clin Esp (Barc) ; 221(10): 592-595, 2021 12.
Article in English | MEDLINE | ID: mdl-34563488

ABSTRACT

INTRODUCTION: The effect of dexamethasone in the initial phase of infection by SARS-CoV-2 and its influence on COVID-19 is not well defined. We describe clinical-radiological characteristics, the cytokine storm parameters, and the clinical evolution of a series of patients treated with dexamethasone in the disease's initial phase. METHOD: A study of 8 patients who received dexamethasone before the development of COVID-19. We evaluate clinical variables, imaging tests, cytokine release parameters, treatment used and patient evolution. RESULTS: All patients received a 6 mg/day dose with a mean duration of 4.5 days before admission. High resolution computed tomography (HRCT) revealed that most of them presented a severe extension; most patients had a slightly elevated level of cytokine release parameters. Three patients required high-flow oxygen therapy due to respiratory failure; none required orotracheal intubation or died. CONCLUSION: Dexamethasone in the early stages of SARS-CoV-2 infection appears to be associated with severe COVID-19.


Subject(s)
COVID-19 Drug Treatment , Cytokine Release Syndrome , Dexamethasone , Humans , SARS-CoV-2
6.
Rev Clin Esp ; 221(10): 592-595, 2021 Dec.
Article in Spanish | MEDLINE | ID: mdl-33716310

ABSTRACT

INTRODUCTION: The effect of dexamethasone in the initial phase of infection by SARS-CoV-2 and its influence on COVID-19 is not well defined. We describe clinical-radiological characteristics, the cytokine storm parameters, and the clinical evolution of a series of patients treated with dexamethasone in the disease's initial phase. METHOD: A study of 8 patients who received dexamethasone before the development of COVID-19. We evaluate clinical variables, imaging tests, cytokine release parameters, treatment used and patient evolution. RESULTS: All patients received a 6 mg/day dose with a mean duration of 4.5 days before admission. High resolution computed tomography (HRCT) revealed that most of them presented a severe extension; most patients had a slightly elevated level of cytokine release parameters. Three patients required high-flow oxygen therapy due to respiratory failure; none required orotracheal intubation or died. CONCLUSION: Dexamethasone in the early stages of SARS-CoV-2 infection appears to be associated with severe COVID-19.

9.
Biol Res Nurs ; 21(1): 107-113, 2019 01.
Article in English | MEDLINE | ID: mdl-30282476

ABSTRACT

BACKGROUND AND AIMS: C-reactive protein (CRP) is commonly used as a biomarker for inflammation. Mild elevations of CRP have been seen in chronic autoimmune diseases like systemic lupus erythematosus (SLE), and CRP has been linked to an increased risk of cardiovascular events. Diet quality and certain dietary factors seem to influence CRP levels in healthy subjects. To date, the effect of diet on serum CRP in SLE has not been studied. Our aim was to investigate the relationship between dietary nutrients, antioxidant intake, and serum CRP in SLE. DESIGN AND METHOD: A cross-sectional study was conducted among 91 patients with SLE. High-sensitivity hsCRP values were determined using an immuno-turbidimetry assay in a Beckman Coulter analyzer (AU5800). Dietary intake of macro- and micronutrients was assessed through a 24-hr diet recall. Antioxidant nutrient intake was evaluated using the dietary antioxidant quality score (DAQs). Linear regression models were used to investigate the relationships between serum hsCRP levels, dietary nutrient intake, and DAQs. RESULTS: The mean serum hsCRP level observed (3.76 ± 6.68 mg/L) was above the established normal range. However, participating SLE patients had low-quality diets, and we found no significant correlations between dietary intake of macro- or micronutrients or antioxidant nutrient intake (DAQs) and serum CRP levels. CONCLUSION: Our study reveals that participating SLE patients had a low-quality diet that did not influence inflammatory status measured using serum CRP levels. Further interventional studies with high-quality diets in this population are necessary to dissect the role of diet on CRP levels in SLE.


Subject(s)
Biomarkers/analysis , C-Reactive Protein/analysis , C-Reactive Protein/immunology , Diet , Energy Intake , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/physiopathology , Adult , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Spain
13.
Medicine (Baltimore) ; 94(43): e1728, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26512564

ABSTRACT

Systemic sclerosis (SSc) is a rare, multisystem disease showing a large individual variability in disease progression and prognosis. In the present study, we assess survival, causes of death, and risk factors of mortality in a large series of Spanish SSc patients. Consecutive SSc patients fulfilling criteria of the classification by LeRoy were recruited in the survey. Kaplan-Meier and Cox proportional-hazards models were used to analyze survival and to identify predictors of mortality. Among 879 consecutive patients, 138 (15.7%) deaths were registered. Seventy-six out of 138 (55%) deceased patients were due to causes attributed to SSc, and pulmonary hypertension (PH) was the leading cause in 23 (16.6%) patients. Survival rates were 96%, 93%, 83%, and 73% at 5, 10, 20, and 30 years after the first symptom, respectively. Survival rates for diffuse cutaneous SSc (dcSSc) and limited cutaneous SSc were 91%, 86%, 64%, and 39%; and 97%, 95%, 85%, and 81% at 5, 10, 20, and 30 years, respectively (log-rank: 67.63, P < 0.0001). The dcSSc subset, male sex, age at disease onset older than 65 years, digital ulcers, interstitial lung disease (ILD), PH, heart involvement, scleroderma renal crisis (SRC), presence of antitopoisomerase I and absence of anticentromere antibodies, and active capillaroscopic pattern showed reduced survival rate. In a multivariate analysis, older age at disease onset, dcSSc, ILD, PH, and SRC were independent risk factors for mortality. In the present study involving a large cohort of SSc patients, a high prevalence of disease-related causes of death was demonstrated. Older age at disease onset, dcSSc, ILD, PH, and SRC were identified as independent prognostic factors.


Subject(s)
Registries , Scleroderma, Systemic/mortality , Adult , Aged , Cause of Death , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , Spain/epidemiology
14.
Lupus ; 24(13): 1356-63, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26162685

ABSTRACT

Antiphospholipid syndrome is considered a high risk factor for any kind of surgery. Considering that all solid organ transplants are critically dependent on the patency of vascular anastomosis, there is much concern about the consequences this pro-thrombotic condition may have on transplantation. Relatively little information is available in the literature assessing the real risk that antiphospholipid syndrome or the presence of antiphospholipid antibodies represent in solid organ transplantation. The aim of this article is to review the literature related to transplantation of solid organs in patients diagnosed with antiphospholipid syndrome or patients with positive antiphospholipid antibodies.


Subject(s)
Antibodies, Antiphospholipid/immunology , Antiphospholipid Syndrome/diagnosis , Organ Transplantation , Antibodies, Anticardiolipin/immunology , Antiphospholipid Syndrome/immunology , Antiphospholipid Syndrome/surgery , Female , Humans , Lupus Coagulation Inhibitor/immunology , Middle Aged , Risk Factors , Thrombophilia/diagnosis , Thrombophilia/etiology , Thrombophilia/therapy , Thrombosis/immunology , Thrombosis/physiopathology , Transplantation Immunology , Treatment Outcome
15.
Lupus ; 24(8): 875-9, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25697771

ABSTRACT

OBJECTIVE: To analyze the role of the antiphospholipid autoantibodies (aPL) on the neuropsychological deficits in systemic lupus erythematosus (SLE) patients, comparing groups of patients with antiphospholipid syndrome (APS; n = 15), SLE with aPL (n = 12), and SLE without aPL (n = 27), and a healthy control group (n = 31). METHODS: Patients fulfilled the American College of Rheumatology SLE classification criteria or the Sydney criteria for APS. All participants were woman, and groups were matched on age and education. A standardized cognitive examination classified patients as cognitively declined or impaired according to the American College of Rheumatology. RESULTS: Differences between the groups were found in all of the studied variables, comprising attention and executive functions (sustained and selective attention, fluency, and inhibition), and memory (verbal and visual). Post-hoc analyses showed cognitive performance was equivalent between APS and SLE with aPL. Differences between SLE without aPL and control groups were found only in four of the 10 studied variables, while differences in all but two memory variables were found between SLE without aPL and control groups. Furthermore, cognitive deficit was three times more frequent in APS and SLE with aPL patients than for the control group (80%, 75%, and 16%, respectively), and two times more frequent compared to SLE patients without aPL (48%). CONCLUSIONS: Our results support the relationship between aPL and cognitive symptoms in SLE. Also, almost half of the patients with SLE and no aPL showed cognitive problems, pointing to the multifactorial causes of cognitive problems in SLE. Future research with larger sample size is guaranteed to replicate our results.


Subject(s)
Antibodies, Antiphospholipid/immunology , Antiphospholipid Syndrome/immunology , Cognition Disorders/epidemiology , Lupus Vasculitis, Central Nervous System/immunology , Lupus Vasculitis, Central Nervous System/psychology , Adult , Attention , Executive Function , Female , Humans , Memory , Middle Aged
16.
Lupus ; 24(2): 130-7, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25199808

ABSTRACT

Pyoderma gangrenosum (PG) is an uncommon, distinctive cutaneous ulceration which is usually idiopathic, but may be associated with many systemic disorders. The etiopathogenesis of PG is still not well understood. PG is part of the spectrum of the neutrophilic dermatoses and it has been proposed as a prototype of cutaneous autoinflammatory disease. PG usually has a good outcome under immunosuppressive treatment. Although PG has been associated with several systemic diseases, it has rarely been reported in association with systemic lupus erythematosus (SLE). In this article we report five cases of SLE-related PG and review the literature. Our findings support the possible relationship between active SLE and PG, although the mechanism remains unclear. Clinical manifestations, used treatments and outcomes of SLE-related PG do not differ from the described for the general population.


Subject(s)
Immunosuppressive Agents/therapeutic use , Lupus Erythematosus, Systemic/complications , Pyoderma Gangrenosum/etiology , Adult , Female , Humans , Male , Middle Aged , Pyoderma Gangrenosum/drug therapy , Pyoderma Gangrenosum/pathology
18.
Conscious Cogn ; 26: 133-44, 2014 May.
Article in English | MEDLINE | ID: mdl-24747992

ABSTRACT

Several studies about schizophrenia have shown a cognitive bias named "Jumping to Conclusions" (JTC), defined as a decision made quickly on the basis of little evidence that occurs in these patients when performing probabilistic reasoning paradigms. The main objective of this study is to compare JTC bias and BADE (Bias Against Disconfirmatory Evidence) in patients with schizophrenia vs. participants with high/low schizotypy to understand the underlying mechanism of these cognitive biases. Probabilistic reasoning was assessed using a modified version of Drawing to Decision task. In addition to the traditional parameters of this task (Plausibility Rating (PR), Draws to Decision (DTD), BADE) we also calculated new parameters, overall accuracy and one named Feedback Sensitivity (FS) which lower scores shows greater use of feedback. The results of the study suggest a context effect: in the cued condition, there were not main differences between groups. In the uncued condition, we found higher JTC bias at stage 1 for patients. At the same time, PR at first stages related positively with Feedback Sensitivity and negatively with accuracy for patients and high schizotypy participants (high confidence is associated with worse performance and lower feedback use). BADE seems unrelated to JTC bias and FS. The results are discussed in terms of JTC like as a clinical bias and whether patients with schizophrenia are less able to use feedback.


Subject(s)
Decision Making/physiology , Feedback, Psychological/physiology , Schizophrenia/physiopathology , Schizotypal Personality Disorder/physiopathology , Thinking/physiology , Adult , Female , Humans , Male
20.
J Chromatogr A ; 1218(30): 4817-27, 2011 Jul 29.
Article in English | MEDLINE | ID: mdl-21481402

ABSTRACT

The heating effect on the soil organic matter (SOM) of a Mediterranean soil was studied in two fractions (macro- and microaggregates) and in two environments (soil under canopy of Quercus coccifera and bare soil between plants). Samples were heated under laboratory conditions at different temperatures (220, 380 and 500°C) to establish their effects on the SOM quality and quantity by comparison with unheated control samples (25°C). The SOM content in the soil under canopy was higher than in the bare one and in the microaggregate fractions than in the macroaggregate ones. Increasing temperatures caused, in general, the decrease of SOM content in both soils as well as in both aggregate classes. The quality of SOM was determined after extraction with 0.1 M NaOH and analysed by pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS). Obtained pyrolysates were characterized by the presence of polyphenols and other aromatic pyrolysis products (lipids, polysaccharides, proteins and lignin derivatives). Some of the products in these control samples, and furthermore the presence of black carbon (BC) markers (e.g. benzene, pyridine and toluene), confirmed the occurrence of past wildfires in the study zone. The composition of the SOM extracted from the soils heated at 220°C, was quite similar to that obtained from unheated soils. The products derived from polysaccharides and lignin, and some coming from polyphenols, were not detected in the pyrolysates of the soil heated at 380 and 500°C.


Subject(s)
Ecological and Environmental Phenomena , Gas Chromatography-Mass Spectrometry/methods , Organic Chemicals/analysis , Soil/chemistry , Fires , Hot Temperature , Mediterranean Region , Organic Chemicals/metabolism , Principal Component Analysis , Quercus , Trees
SELECTION OF CITATIONS
SEARCH DETAIL
...